Meteospasms (Meteospasmyl)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspcapsules
Composition:

For 1 capsule:

Active substances:

Alverina citrate 60 mg,

Simethicone 300 mg.

Excipients:

Soy lecithin is sufficient,

Triglycerides of medium density are sufficient.

Shell composition:

Gelatin 167.02 mg,

Glycerol 84.12 mg,

Titanium dioxide 1.86 mg,

Purified water is sufficient.

Description:Soft, oblong, light yellow glossy capsule size 6, containing a thick suspension of white
Pharmacotherapeutic group:Spasmolytic agent.
ATX: & nbsp
  • Alverin in combination with other drugs
    • Pharmacodynamics:

    Combined drug. Has spasmolytic effect, reduces gas formation in the intestine.

    Alverin - Myotropic antispasmodic, the action of which is not accompanied by an atropine-like effect or ganglion-blocking activity. Reduces the increased tone of smooth muscles of the intestine.

    Simethicone - a hydrophobic polymeric substance with a low surface tension, reducing gassing in the intestine and covering the protective film of the wall of the digestive canal.

    Indications:

    Functional disorders of the gastrointestinal tract, manifested by abdominal pain, increased gas production, belching, nausea, constipation, diarrhea, or alternation.

    Preparation for X-ray, ultrasound or instrumental examination of the abdominal organs.

    Contraindications:Individual intolerance to al'verine citrate and other components of the drug. Children under 14 years.
    Pregnancy and lactation:It is not recommended to use during pregnancy and breastfeeding.
    Dosing and Administration:

    Inside. 1 capsule 2-3 times a day before meals.

    In preparation for studies of the abdominal organs - 1 capsule 2-3 times before the test and 1 capsule on the morning of the day of the study.

    The duration of therapy is determined by the doctor individually.

    Side effects:

    - Rare cases of urticaria, disappearing upon discontinuation of treatment, sometimes with swelling of the larynx or shock.

    - Rare cases of liver function abnormalities, disappearing upon discontinuation of treatment.

    Overdose:No cases of overdose have been reported.
    Interaction:It is not known.
    Effect on the ability to drive transp. cf. and fur:Data on the negative impact of Meteopazmil on the ability to drive a car and perform work that requires a high rate of mental and physical reactions, no.
    Form release / dosage:Capsules.
    Packaging:10 capsules in a blister (PVC / aluminum), 2, 3, 4 blisters with instructions for use in a cardboard bundle.
    Storage conditions:At a temperature not higher than 25 ° C in a place inaccessible to children.
    Shelf life:3 years. Do not use at the end of the expiration date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:П N013069 / 01
    Date of registration:13.12.2007
    Expiration Date:Unlimited
    The owner of the registration certificate:Laboratories MAYOLI-SPINDLERLaboratories MAYOLI-SPINDLER France
    Manufacturer: & nbsp
    Representation: & nbspMAYOLI SPINDLER, LLCMAYOLI SPINDLER, LLCRussia
    Information update date: & nbsp07.05.2018
    Illustrated instructions
      Instructions
      Up